Clinical trial
Chemotherapy for Patients With Non-Small Cell Lung Cancer
NCT00380718 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00380718 |
|---|---|
| Title | Chemotherapy for Patients With Non-Small Cell Lung Cancer |
| Official title | Open-Label Single-Arm Phase IV Study of Pemetrexed in Taiwanese Patients With Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | pemetrexed |
| Enrollment | 33 |
| Start date | Nov 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Nov 1, 2009 |
| First posted | Sep 26, 2006 |
| Last update posted | Nov 16, 2010 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: